Press Releases

Crossix Solutions to Discuss Digital Measurement Innovation at ePharma Summit

Crossix’s Ira Haimowitz will examine key data-driven trends within the rapidly changing digital media landscape during the March 7th session  

NEW YORK, NY – February 14, 2017 – At next month’s ePharma Summit in New York City, Ira Haimowitz, VP, product strategy at Crossix, will explore the latest measurement approaches and expanded data sets that health marketers are using to optimize their digital media campaigns. Informed by Crossix’s experience in measuring more than 100 digital ad campaigns to date, this breakthrough case study will illustrate the innovative ways that a pharma brand leveraged clinical data sets (e.g., diagnosis, lab results) for the first time to obtain more granular insights about its digital media campaign than ever before. 
Entitled “Broader, Deeper, Faster, Better: Innovations in Digital Measurement,” this presentation will enable the audience to better understand:

  • The importance of expanding the data sets traditionally used to measure and optimize digital ad campaigns
  • How clinical metrics provide a more holistic understanding of digital marketing's impact at various stages along the patient continuum
  • Which metrics are with the strongest leading indicators of future new patient starts attributed to digital ads
  • And much more

The presentation will begin promptly at 2:15 p.m. ET on Tuesday, March 7th. Register for the ePharma Summit here, and for those unable to attend in person, a PDF can be shared after the event, by request.

To learn more about Crossix’s digital solutions or our upcoming speaking sessions, contact us

About Crossix Solutions

Crossix partners with leading healthcare and media companies to plan, measure and optimize their marketing and communication initiatives. With deep consumer and healthcare professional expertise, Crossix delivers hard-to-come-by audience and campaign insights to inform strategic business decisions and drive improved patient outcomes. Data-driven and data-proven, the patented Crossix methodology and differentiated technology enable critical connections across its proprietary data network of Rx, OTC, medical, clinical, media and consumer data to ensure more actionable cross-channel measurement with best-in-class privacy safeguards far exceeding HIPAA requirements. The unique Crossix technology aggregates insights from across the data network to pinpoint marketing initiatives that activate the right audiences and generate incremental impact. Founded in 2004, Crossix is headquartered in New York City. Follow Crossix on Twitter at @Crossix.